NeoCore Technology , Ltd. Overview
Get informed when a big investor buys or sells
+ Follow-35.97
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for 4131.TWO is -35.97. That is below the Healthcare sector average of 77.98. Investors often review this figure alongside NeoCore Technology , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, 4131.TWO currently prints -35.97 for P/E ratio, while the sector average sits near 77.98. That is roughly 146.1% below the sector mean. Large gaps often invite a closer look at NeoCore Technology , Ltd.'s growth, margins, and balance sheet.
A P/E ratio of -35.97 for NeoCore Technology , Ltd. is not 'good' or 'bad' on its own. Compare it with the peer average (77.98) and with 4131.TWO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting 4131.TWO's P/E ratio (-35.97), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack NeoCore Technology , Ltd.'s P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
